McCann Corey - Insider Non-Derivative Transactions at Pear Therapeutics, Inc. (PEAR) - (SEC)
Updated on December 12, 2024.
According to recent SEC insider information filed on Jan 20, 2023, McCann Corey's relationship to Pear Therapeutics, Inc. (PEAR) is Director,Officer (President and CEO), and currently has 8,245,565 shares of Common Stock, and 8,210,834 shares of Class A Common Stock.
The the number of shares owned, and the table shows the recent insider transactions.
You can see similar information for other PEAR insiders.
Data Source: SEC.
McCann Corey - Insider Non-Derivative Transactions at PEAR
Items per page:
0 of 0
| Date | Transaction | No. of Shares | Price Per Share | Shares Owned After Transactions |
|---|---|---|---|---|
| Jan 21, 2023 | Sell -- (Class A Common Stock) | 34731 | 1.13 | 8210834 |
| Jan 15, 2023 | M -- (Common Stock) | 88000 | 0 | 8245565 |